Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 21Lymphoma 20Lymphoma, Follicular 16Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma, Non-Hodgkin 10Lymphoma, Mantle-Cell 9Lymphoma, B-Cell, Marginal Zone 9Leukemia 9Recurrence 6Burkitt Lymphoma 6Waldenstrom Macroglobulinemia 5Lymphoma, B-Cell 4Lymphoma, Large-Cell, Immunoblastic 3Hodgkin Disease 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Dendritic Cell Sarcoma, Interdigitating 2Vomiting 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Nausea 1Multiple Myeloma 1Lymphoma, Primary Effusion 1Lymphoma, AIDS-Related 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Hairy Cell 1Intraocular Lymphoma 1

Interventions

Ondansetron 3Granisetron 3Aprepitant 2casopitant 1Vincristine 1Tropisetron 1Therapeutics 1Rituximab 1R-CHOP protocol 1Psychiatric Rehabilitation 1Prochlorperazine 1Prednisolone 1Palonosetron 1Metoclopramide 1Lorazepam 1Exercise 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Antiemetics 1Acupuncture Points 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Vomiting × Rituximab × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡